
The European Union’s drug regulator has recommended the use of two Omicron-tailored vaccines developed by the Pfizer-BioNTech partnership and Moderna Inc ahead of a fresh booster programme this fall across the continent.
The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency (EMA) said in a statement on Thursday.